Prevention of Relapse and Recurrence in Depression

The Role of Long-Term Pharmacotherapy and Psychotherapy

Andrew A. Nierenberg, Timothy J. Petersen, Jonathan E. Alpert

Research output: Contribution to journalReview article

71 Citations (Scopus)

Abstract

Major depressive disorder is a chronic disorder, frequently characterized by relapses and recurrences. One of the major risk factors for additional episodes of depression is the presence of residual symptoms that persist after a depressive episode ends; these residual symptoms tend to progress to another depressive episode. Although relapse or recurrence may be prevented with long-term pharmacotherapy, this approach is recommended only for patients at high risk of relapse or recurrence. Patients not at high risk who are effectively treated to full remission have a substantially lower risk of developing another depressive episode. In addition, psychotherapy, alone or combined with medication, has been shown to be effective in preventing further episodes of depression.

Original languageEnglish (US)
Pages (from-to)13-17
Number of pages5
JournalJournal of Clinical Psychiatry
Volume64
Issue numberSUPPL. 15
StatePublished - 2003
Externally publishedYes

Fingerprint

Secondary Prevention
Psychotherapy
Depression
Recurrence
Drug Therapy
Major Depressive Disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Prevention of Relapse and Recurrence in Depression : The Role of Long-Term Pharmacotherapy and Psychotherapy. / Nierenberg, Andrew A.; Petersen, Timothy J.; Alpert, Jonathan E.

In: Journal of Clinical Psychiatry, Vol. 64, No. SUPPL. 15, 2003, p. 13-17.

Research output: Contribution to journalReview article

@article{68a8ff518db44f3490d6aa2922fd55c0,
title = "Prevention of Relapse and Recurrence in Depression: The Role of Long-Term Pharmacotherapy and Psychotherapy",
abstract = "Major depressive disorder is a chronic disorder, frequently characterized by relapses and recurrences. One of the major risk factors for additional episodes of depression is the presence of residual symptoms that persist after a depressive episode ends; these residual symptoms tend to progress to another depressive episode. Although relapse or recurrence may be prevented with long-term pharmacotherapy, this approach is recommended only for patients at high risk of relapse or recurrence. Patients not at high risk who are effectively treated to full remission have a substantially lower risk of developing another depressive episode. In addition, psychotherapy, alone or combined with medication, has been shown to be effective in preventing further episodes of depression.",
author = "Nierenberg, {Andrew A.} and Petersen, {Timothy J.} and Alpert, {Jonathan E.}",
year = "2003",
language = "English (US)",
volume = "64",
pages = "13--17",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "SUPPL. 15",

}

TY - JOUR

T1 - Prevention of Relapse and Recurrence in Depression

T2 - The Role of Long-Term Pharmacotherapy and Psychotherapy

AU - Nierenberg, Andrew A.

AU - Petersen, Timothy J.

AU - Alpert, Jonathan E.

PY - 2003

Y1 - 2003

N2 - Major depressive disorder is a chronic disorder, frequently characterized by relapses and recurrences. One of the major risk factors for additional episodes of depression is the presence of residual symptoms that persist after a depressive episode ends; these residual symptoms tend to progress to another depressive episode. Although relapse or recurrence may be prevented with long-term pharmacotherapy, this approach is recommended only for patients at high risk of relapse or recurrence. Patients not at high risk who are effectively treated to full remission have a substantially lower risk of developing another depressive episode. In addition, psychotherapy, alone or combined with medication, has been shown to be effective in preventing further episodes of depression.

AB - Major depressive disorder is a chronic disorder, frequently characterized by relapses and recurrences. One of the major risk factors for additional episodes of depression is the presence of residual symptoms that persist after a depressive episode ends; these residual symptoms tend to progress to another depressive episode. Although relapse or recurrence may be prevented with long-term pharmacotherapy, this approach is recommended only for patients at high risk of relapse or recurrence. Patients not at high risk who are effectively treated to full remission have a substantially lower risk of developing another depressive episode. In addition, psychotherapy, alone or combined with medication, has been shown to be effective in preventing further episodes of depression.

UR - http://www.scopus.com/inward/record.url?scp=0344851818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344851818&partnerID=8YFLogxK

M3 - Review article

VL - 64

SP - 13

EP - 17

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - SUPPL. 15

ER -